A Woman With Advanced Alzheimer’s Took Magic Mushrooms and Started Speaking Again

A single case report hints at dormant abilities.

For five years, the woman had mostly stopped speaking.

She was in her 80s, Japanese-American, and had lived with a diagnosis of Alzheimer’s disease for about a decade. By the time doctors described her case, she needed help walking, eating and dressing. She communicated mostly in single syllables.

Then, after receiving a large dose of psilocybin-containing mushrooms, she woke from a long, sleep-like state and began talking about her life.

“Approximately 19 hours after administration, the patient spontaneously initiated autobiographical conversation lasting several hours,” the authors wrote in the case report, published in Frontiers in Neuroscience.

The report has drawn wide-eyed attention because Alzheimer’s disease, especially in its advanced stages, usually moves in one direction. Modern drugs can modestly slow decline in some patients, particularly earlier in the disease. They do not restore years of lost speech, mobility or continence because the damage is already done. The physical consequences of Alzheimer’s are permanent.

That is why this case is striking. It is also why scientists say it should be read carefully. This one case is absolutely remarkable, but it’s no evidence that magic mushrooms reverse dementia.

A Startling Change After a High Dose of Psilocybin

The patient received 5 grams of psilocybin-containing mushrooms of the Enigma strain. That is a high dose. Afterward, she developed profuse sweating, suspected hyperthermia and a prolonged deep sleep-like state.

About 19 hours later, she began speaking spontaneously.

×

Get smarter every day...

Stay ahead with ZME Science and subscribe.

Daily Newsletter
The science you need to know, every weekday.

Weekly Newsletter
A week in science, all in one place. Sends every Sunday.
No spam, ever. Unsubscribe anytime. Review our Privacy Policy.

Thank you! One more thing...

Please check your inbox and confirm your subscription.

Over the next days, caregivers reported changes across several parts of daily life. She recognized family members. She walked independently by the second day and dressed herself. Her diapers remained dry, including at night (the patient had incontinence). She smiled, made eye contact and engaged socially.

One month later, while still improved compared with baseline, she received a second supervised dose of 3 grams. During that session, the researchers say she described “emotionally positive imagery involving surfing with her son on a peaceful island.” She also showed more facial expression, humor and physical agility.

At one point, the patient spontaneously said: “It is pleasant to come here,” according to the case report.

The authors’ interpretation is that the findings “do not imply disease reversal,” they wrote, but suggest that some functional capacity may persist even in late-stage neurodegeneration and become temporarily accessible.

That idea is provocative. It raises the possibility that some brain circuits in advanced dementia may be impaired rather than fully destroyed. But the study cannot prove that.

Why Psilocybin Might Affect the Brain

Psilocybin, the active compound in so-called magic mushrooms, is converted in the body into psilocin. It acts partly through serotonin receptors, especially a receptor called 5-HT2A, which helps regulate communication across brain networks.

In recent years, researchers have studied psilocybin for depression, anxiety, addiction and distress in people facing serious illness. Brain-imaging studies suggest that psychedelics can temporarily loosen rigid patterns of brain activity and increase communication between regions that do not normally interact as strongly.

RelatedPosts

There might be an anti-aging secret hiding in magic mushrooms
A small, portable test could revolutionize how we diagnose Alzheimer’s
Routine, repetitive jobs may put you at higher risk of dementia
Difficulties hearing speech over noise? That may be an early sign of dementia, new study says

“The story is remarkable because the patient reportedly had advanced Alzheimer’s with years of severe impairment, then showed transient gains. That is extraordinary. However, as a neuroscientist who studies serotonin 5-HT2A signaling, I am not surprised that a powerful serotonergic psychedelic could acutely reorganize brain network activity and temporarily reveal capacities that seemed lost,” Dustin Hines, an associate professor of psychology at the University of Nevada, Las Vegas, who was not involved in the study, told Medical News Today.

He added a crucial warning: “The keyword is ‘temporarily.’ This is a single case report, not proof of Alzheimer’s reversal.”

The Limits Are as Important as the Result

The patient’s Alzheimer’s diagnosis was clinical and was not confirmed with biomarkers or advanced brain imaging. The authors did not use standardized cognitive tests, brain scans, sleep monitoring or electrical recordings. Caregivers and clinicians observed the improvements, but there was no control group.

Dementia symptoms can also fluctuate. Without a larger trial, researchers cannot rule out coincidence, placebo effects in observation, changes in care or some other medical explanation.

Psilocybin is not approved by the Food and Drug Administration for medical use. Older adults with dementia may face higher risks from delirium, falls, panic, heart problems, medication interactions and an inability to understand what is happening.

“Do not try this at home on yourself or a loved one with dementia,” Hines said.